Ayahuasca Podcast
Explore Transformative Experiences

and ancestral Plant Medicine

WhatsApp-Image-2023-12-10-at-4.00.42 AM

Founder & Host

Sam Believ

Sam had a life-changing experience with Ayahuasca with the medicine taking away his depression and helping him find his purpose. Now Sam is on a mission to spread the word about Ayahuasca with AyahuascaPodcast.com as well as provide affordable and accessible Ayahuasca experience at his retreat – LaWayra.

LaWayra has become the most reviewed Ayahuasca retreat in South America in 3 years of its existence and has changed lives of 1000s of people.

Enjoy New Shows

Latest episodes

In this episode of Ayahuasca Podcast, host Sam Believ (founder of http://www.lawayra.com) has a conversation with Dan Cleland. Dan is a Canadian entrepreneur, author, and former CEO and co-founder of Soltara Healing Center in Costa Rica. Blending plant medicine, mindset mastery, and social entrepreneurship, he is the author of The Pulse of the Jungle and 12 Laws of the Jungle.

  • 00:00 – 01:05: Introduction to Dan Cleland, his background in heavy metal, and his path as a square peg in the retreat space

  • 01:06 – 05:22: Building Pulse Adventure Tours, Arcana Spiritual Center in Peru, and founding Soltara Healing Center in Costa Rica

  • 05:23 – 09:51: Dan’s early life struggles, lost direction in his 20s, and a life-altering fall off a 20-meter cliff in Australia

  • 09:52 – 14:34: Recovering from severe physical trauma, discovering Ayahuasca, and setting off on a journey to Peru

  • 14:35 – 18:00: Getting robbed in Cusco, suffering food poisoning, and finding his first Ayahuasca ceremony in New Mexico

  • 18:01 – 22:30: Experiencing retreats at Chimbre, writing his early blogs, and building early adventure-based retreat tours

  • 22:31 – 26:40: Working with the Shipibo lineage in Iquitos, launching Pulse Tours, and acquiring land with local community support

  • 26:41 – 30:02: The forging process of Ayahuasca and the resilience needed to run a complex plant medicine center

  • 30:03 – 34:52: Navigating operational chaos, guest safety, facilitator challenges, and supply chain realities in Latin America

  • 34:53 – 38:20: The transformational ripple effect of plant medicine on thousands of retreat guests and local communities

  • 38:21 – 42:17: Balancing the beauty of life-changing transformations with the messy business mechanics of retreat centers

  • 42:18 – 47:08: Raising capital for Soltara, navigating border closures and zero revenue during the pandemic, and scaling back up

  • 47:09 – 49:52: Facing market saturation in Costa Rica, shifting industry dynamics, and deciding to transition out of Soltara

  • 49:53 – 54:25: The difficulty of scaling retreat models, personal founder touches, and Dan’s book 12 Laws of the Jungle

  • 54:26 – 1:00:18: Key principles from 12 Laws of the Jungle: “The jungle doesn’t care,” gladiator mindsets, and hunting for deals

  • 1:00:19 – 1:04:03: The Cashflow Quadrant framework, shifting from employee to business owner, and life post-exit

  • 1:04:04 – 1:08:18: Staying active through new ventures, documentaries (Drinking the Jungle), and closing advice

If you would like to attend one of our Ayahuasca retreats go to http://www.lawayra.com.

Find more about Dan Cleland at Daniel Cleland’s Website or on Instagram @danielccleland.

In this episode of the Ayahuasca Podcast, host Sam Believ speaks with Bruce Eckfeldt—a seasoned entrepreneur, systems thinker, certified exit planning advisor, former CEO of an Inc. 500 tech firm, and host of the Psychedelics Invest podcast.

  • 00:00 – 01:00: Introduction of guest Bruce Eckfeldt, highlighting his background as an architect, tech founder, exit planning advisor, and host of Psychedelics Invest.

  • 01:01 – 04:04: Bruce shares his personal journey from architecture to interactive tech, selling his company in 2013, recovering from a broken back using cannabis, and transitioning into the cannabis and psychedelic podcast space.

  • 04:05 – 05:15: Sam and Bruce discuss using podcasting as an effective tool for learning and connecting with people.

  • 05:16 – 09:30: Bruce details his first personal psychedelic experience—a weekend retreat involving psilocybin and San Pedro in the California Redwoods—and the deep sense of internal trust and connectedness it provided.

  • 09:31 – 14:00: A discussion on executive and founder burnout, where Bruce redefines burnout not as overexertion, but as an integrity issue stemming from putting energy into work that lacks alignment with personal values.

  • 14:01 – 18:30: Sam and Bruce discuss founder dynamics, the natural life cycle of business stages, energy allocation, and the typical 5- to 7-year life shift cycle.

  • 18:31 – 21:00: Addressing the rumor/fear in Silicon Valley of founders drinking Ayahuasca and quitting their companies or drastically altering their lives.

  • 21:01 – 24:00: Bruce explains his intensive retreat format for executive teams, using natural settings, discomfort, and strategic reflection to drive organizational change.

  • 24:01 – 28:50: Exploring the potential of combining plant medicine with business retreats to treat burnout, alongside the importance of doing internal work before making radical external life changes.

  • 28:51 – 32:25: Unpacking why entrepreneurs build businesses—balancing purpose versus proving oneself—and using the analogy of picking a mountain to climb.

  • 32:26 – 34:25: Why successful people struggle to enjoy their achievements, shifting the focus from fleeting happiness to deep engagement and purpose.

  • 34:26 – 39:30: Bruce introduces his book, Springboard, which guides founders on post-exit planning, scaling, and reverse-engineering their business exit strategies.

  • 39:31 – 44:50: Examining “conscious capitalism” and the intersection/tension between business investors, clinical researchers, and traditional ceremonial plant medicine practices.

  • 44:51 – 49:25: How leaders should integrate psychedelic insights without impulsively disrupting their organizations or teams.

  • 49:26 – 52:25: Recurring visual realms, geometry, and neural patterns experienced during psychedelic journeys.

  • 52:26 – 53:25: Closing remarks and where to find Bruce Eckfeldt’s work (on his LinkedIn, and his book Springboard).

Most DMT experiences are famously brief. A person may enter an intense altered state, encounter vivid landscapes or apparent entities, and begin returning to ordinary consciousness before they have time to understand what is happening. Daniel McQueen believes extended-state DMT could change that.

In a conversation with Ayahuasca Podcast host Sam Believ, McQueen discusses DMTX, a method designed to maintain the DMT state through a controlled infusion. They explore entities, consciousness, cannabis-assisted psychedelic work, and psychedelics as tools for exploration.

What Is DMTX?

DMTX is short for extended-state or stable-state DMT. McQueen explains that the concept grew from work proposed by researcher Andrew Gallimore in collaboration with DMT researcher Rick Strassman.

Instead of smoking or vaping DMT, the approach uses an infusion pump to administer pure DMT into the bloodstream at a controlled rate. Because DMT acts and metabolizes rapidly, the infusion can be adjusted to maintain different levels of the experience.

According to McQueen, the dose can be increased, reduced, or stopped, allowing participants to return toward ordinary consciousness rapidly. This differs from smoked DMT, where the journey is intense but short.

Staying in the DMT State for Hours

McQueen says his group has facilitated around 30 extended-state DMT sessions. Some participants have remained in the experience for two or more hours, while one of his own sessions lasted about three hours.

The goal is not necessarily to remain at maximum intensity. Instead, facilitators can attempt to stabilize participants at different subjective levels. McQueen describes moving through experiences involving ancestors, entities, geometric forms, and more abstract states of unity.

He also emphasizes that the work remains preliminary. Individual responses differ, and even with precise dosing, he does not believe facilitators can fully control what someone will experience.

Encounters With Entities

One unusual aspect of the conversation concerns entities. McQueen says encounters with apparent beings are common in the DMTX sessions he has observed, although they do not occur for everyone.

Participants have reported human-like ancestors, animal or insect-like beings, serpents and dragons, geometric entities, Buddhas, and forms that seem completely unfamiliar. Others experience a presence without seeing a distinct being.

McQueen treats these encounters respectfully while acknowledging that he cannot prove what they are. He describes himself as having both a spiritual interpretation and a skeptical side. Whether the entities are independent beings, aspects of consciousness, archetypes, or something else remains an open question.

Can the DMT Realm Be Mapped?

Extended-state DMT introduces a fascinating possibility: instead of briefly glimpsing an altered state, could researchers eventually study different levels of it systematically?

McQueen says repeated sessions suggest that some themes and experiential spaces may be reproducible for an individual at similar dosing levels. He describes encountering ancestral imagery during two separate journeys at comparable levels.

That raises the possibility of combining controlled dosing with brain monitoring to investigate whether physiological states correspond with particular subjective experiences. McQueen describes much of this as theoretical and preliminary rather than established science.

Beyond Healing: Psychedelics as Exploration

For McQueen, healing is only one reason humans might work with psychedelics. He believes modern psychedelic culture’s focus on treatment can sometimes overlook curiosity and exploration.

He compares psychedelic exploration to earlier eras when people crossed oceans, climbed mountains, explored Antarctica, or looked toward space. Altered states, in his view, may represent another frontier for investigating consciousness and the nature of reality.

DMTX interests him because the experience can potentially be stabilized long enough for someone to orient themselves and examine it rather than simply being swept through it.

Cannabis as a Psychedelic Medicine

McQueen also discusses his long relationship with cannabis. Beginning around 2013, he started exploring whether cannabis could be used intentionally to produce psychedelic states rather than simply recreational effects.

His work eventually developed into cannabis-assisted psychedelic therapy. He describes using carefully structured sessions in his Boulder practice and approaching cannabis as a medicine and ceremonial ally.

He also acknowledges its potential for problematic use. Rather than treating cannabis as entirely good or bad, McQueen favors a harm-reduction approach based on intentionality, accountability, and understanding why someone is using it.

A New Frontier for Consciousness

The larger question behind DMTX remains unanswered: are these experiences generated within the brain, or do they provide access to something beyond ordinary consciousness?

McQueen does not claim to know. What excites him is investigating the question more carefully. Extended-state DMT may allow explorers and researchers to spend more time observing experiences that previously lasted only minutes.

For McQueen, that spirit of curiosity matters. Psychedelics may help people work through difficult experiences and change their lives, but they may also invite deeper questions about consciousness, spirituality, and reality itself. DMTX represents one experimental attempt to stay in that unknown territory long enough to look around.

Listen to the whole podcast episode here: https://open.spotify.com/episode/6XU1dkKvjBEGsGp05Z91Lm?si=yMgmwWxZQ9mL4l3ZV7Zjdg

Join our

Podcast

Learn everything about Ayahuasca

In each episode of Ayahuasca podcast we explore the history, cultural meaning, and personal journeys related to this special plant medicine. We talk with shamans, researchers, and people who share their own

Title
.